• What's involved: A multi-centre, double-blind, randomised, controlled clinical trial of Rifaximin to reduce infection in patients admitted to hospital with decompensated cirrhosis
  • Take part: Closed
  • Principal Investigator: Professor Stephen Ryder
Research Theme | Gastrointestinal & Liver

What's involved

A multi-centre, double-blind, randomised, controlled clinical trial of Rifaximin to reduce infection in patients admitted to hospital with decompensated cirrhosis

Principal Investigator

Professor Stephen Ryder

Take part

Closed
Back to all trials

Website by Volute